市場調查報告書

血液診斷的全球市場:未來展望與預測

Global Hematology Diagnostics Market Outlook and Projections, 2019-2027

出版商 Research Nester 商品編碼 920991
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
血液診斷的全球市場:未來展望與預測 Global Hematology Diagnostics Market Outlook and Projections, 2019-2027
出版日期: 2019年12月19日內容資訊: 英文 189 Pages
簡介

本報告提供全球血液市場未來展望相關分析,彙整市場基本結構和最新形勢,技術開發的動向和開發與普及的動向,整體市場規模趨勢預測 (總計10年份),各產品·攜帶·各用途·各終端用戶及地區別·各國詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等資訊,為您概述為以下內容。

第1章 簡介

第2章 前提條件,簡稱一覽

第3章 分析方法

  • 變數 (獨立·因變數)
  • 基於多元素的靈敏度模型

第4章 摘要整理 - 全球血液診斷市場

第5章 主要市場機會

第6章 法規環境

第7章 設備的一覽

  • 血液診斷
  • 搭配診斷

第8章 搭配診斷的應用領域 (概要):藥效學/藥物動力學額的情況

第9章 市場動態分析

  • 推動市場要素
  • 阻礙市場要素
  • 市場趨勢

第10章 市場風險分析

  • 需求風險分析
  • 供給風險分析

第11章 全球血液診斷市場未來展望

  • 市場規模與其預測 (以金額為準,總計10年份)
  • 市場規模與其預測:各領域 (以金額為準,總計10年份)
    • 各產品:試劑,診斷·分析設備,軟體·服務
    • 各攜帶:POC (照護現場) 設備,獨立式設備
    • 各用途
      • 腫瘤,瘧疾,血液常規檢查,血小板功能,其他 (HIV,糖尿病,遺傳性難治疾病)
      • 貧血 (鐮刀狀紅血球缺乏症,地中海型貧血),其他 (維他命缺乏性貧血,缺鐵性貧血等))
    • 各終端用戶:醫院,診斷檢驗室,當天返回手術中心 (ASC),診所,其他 (教育·研究機關等)

第12章 北美的血液診斷市場未來展望

  • 市場規模與其預測 (以金額為準,總計10年份)
  • 宏觀經濟指標:各國
  • 市場規模與其預測:各領域 (總計10年份)
    • 各產品
    • 各攜帶
    • 各用途
    • 各終端用戶
    • 各國 (美國,加拿大)

第13章 歐洲的血液診斷市場未來展望

  • 市場規模與其預測:各領域 (總計10年份)
    • 各國 (英國,德國,法國,義大利,俄羅斯,西班牙等)

第14章 亞太地區的血液診斷市場未來展望

  • 市場規模與其預測:各領域 (總計10年份)
    • 各國 (中國,印度,日本,馬來西亞,韓國,澳洲等)

第15章 南美的血液診斷市場未來展望

  • 市場規模與其預測:各領域 (總計10年份)
    • 各國 (墨西哥,巴西等)

第16章 中東·非洲的血液診斷市場未來展望

  • 市場規模與其預測:各領域 (總計10年份)
    • 各國 (以色列,南非,沙烏地阿拉伯,UAE等)

第17章 企業結構

  • 概要
  • 主要產品/服務的評估
  • 成長策略分析
  • 主要的財務指標:綜合分析
  • 各地區的市場影響
  • 主要企業聯盟處和合作關係
  • 近幾年趨勢
  • 企業簡介
    • ABBOTT
    • Sysmex
    • BECKMAN COULTER, INC.
    • SIEMENS HEALTHCARE GMBH
    • BOULE DIAGNOSTICS AB
    • F. HOFFMANN-LA ROCHE LTD
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • BIO-RAD LABORATORIES, INC.
    • CELLAVISION
    • 其他的企業

第18章 策略建議

目錄

The global hematology diagnostics market reached USD 4,702.88 million in 2018 and is expected to reach USD 7,989.73 million by 2027, by registering a CAGR of 6.06%, across the globe. This is primarily attributed to the growing demand for advanced diagnostics across the world.

North America had a market share of 37.94% in the year 2018 and is expected to dominate the market, over the forecast period. The growth in the region can be attributed to increase in investments towards healthcare from government and private entities to maintain the highest quality of care offered in healthcare facilities. The US is the major country driving the growth in the region, reaching a market value of USD 1,567.36 million in 2018 and is expected to grow at a CAGR of 6.23% over the forecast period i.e. 2020-2027. On the back of rising adoption of innovative diagnostic methods focused on minimally in-vitro diagnostics, the market is expected to grow over the forecast period.

The Asia Pacific region captured a market size of USD 1,002.46 million in the year 2018 and is expected to reach USD 1,820.23 million by 2027, with a CAGR of 6.85%. The market is primarily led by the demand from China, with a market of USD 367.57 million in the year 2018, and it is expected to grow at a CAGR of 7.75%. With the rising availability of advanced healthcare in this region along with rising number of manufacturers investing in countries such as China, Japan, & India to address the growing demand for advanced diagnostics in this region, the demand for hematology diagnostics products in this region is expected to witness a rapid growth over the forecast period.

Europe is expected to reach a market size of USD 2,114.07 million by 2027. It has been observed that with the availability of innovative treatment modalities, there has been a rise in demand for effective diagnostic products in the region for time sensitive diagnosis. Primarily driven by the demand from Germany, UK, France & Italy, this region is expected to showcase a high demand over the forecast period.

In comparison, the Latin America and Middle East & Africa region is presently generating a moderate demand for the hematology diagnostics products. It has been observed that there are a high number of patients, who opt for various medical procedures, travelling to other geographies with adequate healthcare resources. While this boosts the medical tourism in the travelled country, it points out the wide gap in the availability of health resources in these regions. However, with gradually rising disposable income, encouraging government regulatory policies, and a potential interest of global manufacturers to have a direct market presence in this region, it is expected that the market for hematology diagnostics in these regions would grow over the forecast period.

1. INTRODUCTION

  • 1.1. MARKET DEFINITION
  • 1.2. MARKET SEGMENTATION
  • 1.3. PRODUCT OVERVIEW

2. ASSUMPTIONS AND ACRONYMS

3. RESEARCH METHODOLOGY

  • 3.1. VARIABLES (DEPENDENT AND INDEPENDENT)
  • 3.2. MULTI FACTOR BASED SENSITIVITY MODEL

4. EXECUTIVE SUMMARY - GLOBAL HEMATOLOGY DIAGNOSTICS MARKET

5. KEY MARKET OPPORTUNITIES

6. REGULATORY LANDSCAPE

7. LIST OF DEVICES

  • 7.1. HEMATOLOGY DIAGNOSTICS
  • 7.2. COMPANION DIAGNOSTICS

8. OVERVIEW OF APPLICATIONS OF COMPANION DIAGNOSTICS IN PHARMACODYNAMICS/PHARMACOKINETICS

9. ANALYSIS OF MARKET DYNAMICS

  • 9.1. DRIVERS
  • 9.2. RESTRAINTS
  • 9.3. TRENDS

10. MARKET RISK ANALYSIS

  • 10.1. DEMAND RISK ANALYSIS
  • 10.2. SUPPLY RISK ANALYSIS

11. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 11.1. MARKET SIZE AND FORECAST, 2018-2027
    • 11.1.1. BY VALUE (USD MILLION)
  • 11.2. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 11.2.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 11.2.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 11.2.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 11.2.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

12. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 12.1. MARKET SIZE AND FORECAST, 2018-2027
    • 12.1.1. BY VALUE (USD MILLION)
  • 12.2. MACROECONOMIC INDICATORS, BY COUNTRY
  • 12.3. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 12.3.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 12.3.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 12.3.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 12.3.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

    • 12.3.5. BY COUNTRY

US AND CANADA, 2018-2027F (USD MILLION)

13. EUROPE HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 13.1. MARKET SIZE AND FORECAST, 2018-2027
    • 13.1.1. BY VALUE (USD MILLION)
  • 13.2. MACROECONOMIC INDICATORS, BY COUNTRY
  • 13.3. EUROPE HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 13.3.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 13.3.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 13.3.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 13.3.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

    • 13.3.5. BY COUNTRY

UK, GERMANY, FRANCE, ITALY, RUSSIA, SPAIN, AND REST OF EUROPE, 2018-2027F (USD MILLION)

14. ASIA PACIFIC HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 14.1. MARKET SIZE AND FORECAST, 2018-2027
    • 14.1.1. BY VALUE (USD MILLION)
  • 14.2. MACROECONOMIC INDICATORS, BY COUNTRY
  • 14.3. ASIA PACIFIC HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 14.3.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 14.3.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 14.3.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 14.3.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

    • 14.3.5. BY COUNTRY

CHINA, INDIA, JAPAN, MALAYSIA, SOUTH KOREA, AUSTRALIA, AND REST OF ASIA PACIFIC, 2018-2027F (USD MILLION)

15. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 15.1. MARKET SIZE AND FORECAST, 2018-2027
    • 15.1.1. BY VALUE (USD MILLION)
  • 15.2. MACROECONOMIC INDICATORS, BY COUNTRY
  • 15.3. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 15.3.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 15.3.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 15.3.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 15.3.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

    • 15.3.5. BY COUNTRY

MEXICO, BRAZIL AND REST OF LATIN AMERICA, 2018-2027F (USD MILLION)

16. MIDDLE EAST & AFRICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK

  • 16.1. MARKET SIZE AND FORECAST, 2018-2027
    • 16.1.1. BY VALUE (USD MILLION)
  • 16.2. MACROECONOMIC INDICATORS, BY COUNTRY
  • 16.3. MIDDLE EAST & AFRICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
    • 16.3.1. BY PRODUCT

REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)

    • 16.3.2. BY PORTABILITY

POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)

    • 16.3.3. BY APPLICATIONS

ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)

ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)

    • 16.3.4. BY END USER

HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)

    • 16.3.5. BY COUNTRY

ISRAEL, SOUTH AFRICA, SAUDI ARABIA, UAE, AND REST OF MIDDLE EAST & AFRICA, 2018-2027F (USD MILLION)

17. COMPETITIVE STRUCTURE

  • 17.1. DETAILED OVERVIEW
  • 17.2. ASSESSMENT OF KEY PRODUCT OFFERINGS
  • 17.3. ANALYSIS OF GROWTH STRATEGIES
  • 17.4. EXHAUSTIVE ANALYSIS ON KEY FINACIAL INDICATORS
  • 17.5. REGIONAL PRESENCE
  • 17.6. KEY PARTNERS AND COLLABORATIONS
  • 17.7. RECENT NEWS AND DEVELOPMENTS
  • 17.8. COMPANY PROFILES

ABBOTT

SYSMEX

BECKMAN COULTER, INC.

SIEMENS HEALTHCARE GMBH

BOULE DIAGNOSTICS AB

F. HOFFMANN-LA ROCHE LTD

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

BIO-RAD LABORATORIES, INC.

CELLAVISION

OTHER PROMINENT PLAYERS

18. STRATEGIC RECOMMENDATIONS